Qual a relação existente entre coagulopatias e gestantes com Covid-19? Uma revisão de literatura
DOI:
https://doi.org/10.34119/bjhrv6n2-120Keywords:
gestação, Covid-19, coagulopatias, enfermagem, marcadores bioquímicosAbstract
Objetivo: Analisar dados após compilação através de uma revisão integrativa de literatura, buscando determinar uma possível relação entre gestantes com COVID-19 e coagulopatias, além de mapear alterações de exames laboratoriais que permitam monitorar essa situação, com a finalidade de ampliar e aprimorar a assistência de enfermagem no cuidado dessas pacientes. Método: Trata-se de uma revisão integrativa orientada através da seguinte questão norteadora: “é possível determinar uma relação entre gestante com COVID-19, coagulopatias e as alterações em exames laboratoriais que permitem diagnosticar e monitorar essa situação?”. Os artigos foram compilados nas bases de dados PubMed, LILACS, CINAHL e Web of Science, através da seguinte combinação de palavras: “pregnancy and COVID-19 and coagulopathy”. Resultados: Foram elencados 50 artigos para revisão e, destes, 29 artigos atenderam aos critérios pré-estabelecidos. Desde o início da pandemia, nota-se casos de gestantes com diferentes graus de comprometimento devido à infecção por SARS-CoV-2. Digno de nota, ficam cada vez mais evidentes as pesquisas e relatos de caso associando a potencialização do desenvolvimento de coagulopatias em gestantes com COVID-19, mesmo aquelas assintomáticas. Conclusão: não há marcadores bioquímicos específicos para avaliar a relação estabelecida, entretanto, é fulcral investigar as alterações bioquímicas já associadas às coagulopatias/gestação e COVID-19 para que sejam úteis no diagnóstico precoce e monitoramento adequado dessas pacientes.
References
Albuquerque LP, Monte AVL, Araújo RMS. Implicações da COVID-19 para pacientes gestantes. Implicações da COVID-19 para pacientes gestantes. Rev. Eletrônica Acervo Saúde. 2020; 12(10), e4632.
Almeida MFB, Neri BR, Lima GB, et al. A diferença no monitoramento e manejo de eventos tromboembólicos em gestantes com COVID-19. Rev. Multidisciplinar em Saúde. 2021;2(1).
Aminimoghaddam S, Afrooz N, Nasiri SO, et al. A COVID‑19 pregnant patient with thrombotic thrombocytopenic purpura: A case report. J Med Case Reports 2021;15, 104.
Ariens R, Becattini C, Bender M, et al. Illustrated state-of-the-art capsules of the ISTH 2020 Congress. Res Pract Thromb Haemost. 2020;4(5).
Azarkish F, Sheikhi F, Mirzakhani Z, et al. Preeclampsia and the crucial postpartum period for COVID-19 infected mothers: A case report. Pregnancy Hypertens. 2021;23:136,139.
Bahia L. N. da S., Artiaga L. P., Almeida M. S.,et al. Distúrbios da coagulação em pacientes obstétricas infectadas pelo SARS-CoV-2 (COVID-19). Rev Eletr Acervo Científico, 2021;25, e7077.
Benhamou D, Keïta H, Ducloy-Bouthors AS. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesth Crit Care Pain Med. 2020;39:351-353.
Fabregues F, Peñarrubia J. Assisted reproduction and thomboembolic risk in the COVID-19 pandemic. Reprod Biomed Online. 2020;41(3):361-364.
Ghati N, Roy A, Bhatnagar S, et al. Atorvastatin and aspirin as adjuvant therapy in patients with SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):902.
Hermes Pardini. Manual de Exames Hermes Pardini: medicina, saúde e bem-estar. 1. ed:2015-2016. 573 p.
Kadir RA, Kobayashi T, Iba T, et al. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations and ISTH registry communication from the ISTH SSC for Women’s Health. J Thromb Haemost. 2020;18(11):3086-3098.
Goudarzi S, Firouzabadi F, Mahmoudzadeh F, et al. Pulmonary embolism in pregnancy with COVID-19 infection: A case report. Clin Case Rep. 2021;9(4):1882-1886.
Iba T, Levy JH, Levi M, et al. Coagulopathy of Coronavirus disease 2019. Crit Care Med. 2020;48(9):1358-1364.
Katz R, Efremov V, Mooney C, et al. Assessment of the reliability and validity of a novel point-of-care fibrinogen (F-Point) device against an industry standard at fibrinogen levels >2 g/L in non-haemorrhage. Int J Obstet Anesth. 2020;43:91-96.
Kinsey KE, Ganz E, Khalil S, et al. Intraoperative coagulopathy during cesarean section as an unsuspected initial presentation of COVID-19: A case report. BMC Pregnancy Childbirth. 2020;20(1):481.
Koumoutsea E, Vivanti A, Benachi A, et al. COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost. 2020;18(7):1648-1652.
Llau JV, Ferrandis R, Sierra P, et al. Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19. Rev Esp Anestesiol Reanim. 2020;67(7):391-399.
Makatsariya AD, Slukhanchuk EV, Bitsadze VO, et al. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state. J Matern Fetal Neonatal Med. 2020;6:1-9.
Marietta M, Vandelli P, Mighali P, et al. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol. Trials. 2020;21(1):574.
Mascarenhas VHA, Becker AC, Venâncio KCMP, et al. COVID-19 e a produção de conhecimento sobre as recomendações na gravidez: revisão de escopo. Rev Latino-Am. Enfermagem. 2020;28:e3348.
Mendes KDS, Silveira RCCP, Galvão CM. Integrative literature review: a research method to incorporate evidence in health care and nursing. Texto Contexto Enferm. 2008; 17(4):758-64.
Ministério da Saúde (BR). Secretaria de Atenção Primária à Saúde Departamento de Promoção da Saúde. Manual de recomendações para assistência a gestante e puérperas frente a pandemia de COVID-19; 2020.
Minussi BB, Paludo EA, Passos JPB, et al. Grupos de risco COVID-19: a possível relação entre o acometimento de adultos jovens “saudáveis" e a imunidade. Braz. J. Hea. Rev. 2020;3(2):3739-3762.
Mongula JE, Frenken MWE, van Lijnschoten G, et al. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet Gynecol. 2020;56(5):773-776.
Norooznezhad, AH, Nurzadeh, M., Darabi, MH et al. Coronavirus 2019 disease (COVID-19) in a pregnant woman with treatment-resistant thrombocytopenic purpura and suspected HELLP syndrome: case report. BMC Pregnancy Childbirth 2021;21, 567.
Patberg ET, Adams T, Rekawek P, et al. Coronavirus disease 2019 infection and placental histopathology in women delivering at term. Am J Obstet Gynecol. 2021;224(4):382.e1-382.e18.
Peiris S, Mesa H, Aysola A, et al. Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS One. 2021;16(4):e0250708.
Picanço MBM, Lima ER, Lima GB, et al. Aspectos fisiopatológicos e clínico-laboratoriais das coagulopatias desenvolvidas por pacientes infectados pelo SARS-CoV-2. Rev. Multidisciplinar em Saúde. 2021;2(1).
Pillay PS, Piercy CN, Tolppanen, et al. Physiological changes in Pregnancy, Africa. Cardiovasc. J. Afr, 2016; 27: 89-94.
Prehl VB, Moura GLC, Dias FCF, Rosa RTAS, Junior, et al. Etiopatogenia e diagnóstico da trombose venosa profunda na gestação: revisão de literatura. Rev Pat do Tocantins. 2018;5(4):51-55.
Radwi M, Farsi S. A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost. 2021;19(6):1515-1518.
Ramalingam S, Arora H, Gunasekaran K, et al. Isolated radial vein thrombosis: Upper extremity deep vein thrombosis in a patient with COVID-19 infection. Cureus. 2021;13(1):e12856.
Ramos W, Quiulo L, Fernandes C, et al. Trombofilia e gestação: uma revisão integrativa da literatura. Anais III Conbracis. Campina Grande: Realize Editora, 2018.
Rodrigues A, Lacerda L, Francisco RPV., 'Brazilian Obstetric Observatory'. Disponível em: https://observatorioobstetrico.shinyapps.io/covid_gesta_puerp_br/.
Rasmussen SA, Smulian JC, Lednicky JA, et al. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020;222(5):415-426.
Ronnje L, Länsberg JK, Vikhareva O, et al. Complicated COVID-19 in pregnancy: A case report with severe liver and coagulation dysfunction promptly improved by delivery. BMC Pregnancy Childbirth. 2020;20(1):511.
Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275.
Rushakoff JA, Polyak A, Caron J, et al. A case of a pregnant patient with COVID-19 infection treated with emergency c-section and extracorporeal membrane oxygenation. J Card Surg. 2021;1-4.
Servante J, Swallow G, Thornton JG, et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: A systematic review and critical analysis. BMC Pregnancy Childbirth. 2021;21(1):108.
Silva MRF, Souza KS, Oliveira MBM. Dímero-D: Fator limitante para o prognóstico de pacientes com COVID-19. Rev. Multidisciplinar em Saúde. 2020;1(2).
Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: a pragmatic randomised controlled trial of therapeutic anticoagulation versus standard care as a rapid response to the COVID-19 pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):202.
Souza MT, da Silva MD, de Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010.
Syeda S, Baptiste C, Breslin N, et al. The clinical course of COVID in pregnancy. Semin Perinatol. 2020;44(7):151284. doi: 10.1016/j.semperi.2020.151284.
Takayama W, Endo A, Yoshii J, et al. Severe COVID-19 pneumonia in a 30-year-old woman in the 36th week of pregnancy treated with postpartum extracorporeal membrane oxygenation. Am J Case Rep. 2020;21:e927521.
Yousefi M, Sadriirani M, PourMahmoudi A, et al. Effects of pomegranate juice (Punica granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: A structured summary of a study protocol for a randomized clinical trial. Trials. 2021;22(1):246.
Zhou J, Wang Y, Zhao J, et al. The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates. Eur J Clin Microbiol Infect Dis. 2021;40(3):565-574.
